NYSE American - Delayed Quote USD

cbdMD, Inc. (YCBD)

0.8711 -0.0289 (-3.21%)
At close: April 26 at 3:58 PM EDT
0.8711 0.00 (0.00%)
After hours: April 26 at 5:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
23,445.5490
24,155.3620
35,403.2240
44,480.7630
41,883.7340
Cost of Revenue
8,478.1580
9,177.7030
13,066.6390
14,495.0630
15,514.7270
Gross Profit
14,967.3910
14,977.6590
22,336.5850
29,985.7000
26,369.0070
Operating Expense
21,255.5950
24,246.2080
39,647.1300
49,601.6910
43,950.8610
Operating Income
-6,288.2040
-9,268.5490
-17,310.5450
-19,615.9910
-17,581.8540
Net Non Operating Interest Income Expense
34.1650
63.7020
16.2460
-28.9300
39.8770
Other Income Expense
-13,724.6100
-13,733.3620
-52,789.3940
-4,644.9690
28,847.9340
Pretax Income
-19,978.6480
-22,938.2090
-70,083.6930
-24,289.8890
11,305.9560
Tax Provision
--
--
--
-895.0000
-1,345.3000
Net Income Common Stockholders
-23,980.6470
-26,940.2090
-74,085.6980
-25,949.4980
12,235.4230
Diluted NI Available to Com Stockholders
-23,980.6470
-26,940.2090
-74,085.6980
-25,949.4980
12,235.4230
Basic EPS
-10.29
-13.32
-55.80
-21.15
12.60
Diluted EPS
-10.29
-13.32
-55.80
-21.15
12.60
Basic Average Shares
2,427.2370
2,022.3200
1,327.7840
1,220.8470
980.8960
Diluted Average Shares
2,427.2370
2,022.3200
1,327.7840
1,220.8470
1,003.8140
Total Operating Income as Reported
-19,507.2030
-22,487.5490
-78,266.5150
-19,615.9900
-17,581.8550
Rent Expense Supplemental
--
--
--
--
1,539.6530
Total Expenses
29,733.7530
33,423.9110
52,713.7690
64,096.7540
59,465.5880
Net Income from Continuing & Discontinued Operation
-19,978.6480
-22,938.2090
-70,083.6930
-23,394.8890
12,602.2730
Normalized Income
-6,254.0380
-9,204.8470
-17,055.0490
-18,893.3956
-8,407.7358
Interest Income
--
63.7020
16.2460
--
39.8770
Interest Expense
--
--
--
28.9300
--
Net Interest Income
34.1650
63.7020
16.2460
-28.9300
39.8770
EBIT
-6,288.2040
-9,268.5490
-17,310.5450
-24,260.9590
-17,581.8540
EBITDA
-3,440.4260
-6,340.8340
-14,340.0840
-22,007.1540
-15,680.8860
Reconciled Cost of Revenue
7,337.3590
8,050.7270
11,929.5040
13,258.6670
14,334.5130
Reconciled Depreciation
2,847.7780
2,927.7150
2,970.4610
2,253.8050
1,900.9680
Net Income from Continuing Operation Net Minority Interest
-19,978.6480
-22,938.2090
-70,083.6930
-23,394.8890
12,651.2560
Total Unusual Items Excluding Goodwill
-13,724.6100
-13,733.3620
-53,028.6440
-4,674.4480
28,847.9340
Total Unusual Items
-13,724.6100
-13,733.3620
-53,028.6440
-4,674.4480
28,847.9340
Normalized EBITDA
10,284.1840
7,392.5280
38,688.5600
-17,332.7060
-44,528.8200
Tax Rate for Calcs
--
--
--
0.0000
0.0003
Tax Effect of Unusual Items
--
--
--
-172.9546
7,788.9422
9/30/2020 - 11/17/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CWBHF Charlotte's Web Holdings, Inc.
0.2000
-0.26%
 
RGC Regencell Bioscience Holdings Limited
5.35
-5.31%
 
QLI Qilian International Holding Group Limited
0.7486
-4.03%
 
SXTC China SXT Pharmaceuticals, Inc.
1.0500
+1.94%
 
IMCC IM Cannabis Corp.
0.5548
-2.12%
 
CBDLD CBD Life Sciences Inc.
0.0063
-17.37%
 
GDNSF Goodness Growth Holdings, Inc.
0.4344
+3.43%
 
FLGC Flora Growth Corp.
1.3600
-11.69%
 
IXHL Incannex Healthcare Inc.
2.2200
-3.48%
 
EVOK Evoke Pharma, Inc.
0.4580
+2.92%